Profile

Antiverse

Antiverse is building a world-first computational antibody drug discovery platform. They combine in-house lab expertise with state of the art machine learning to predict antibody-antigen binding and provide antibody drug candidates in one day.

Status current

Associated Fund UK Innovation & Science Seed Fund

Sector Medical / Biotechnology

Website www.antiverse.io/

Associated Team Members

Blog

Burgeoning Sectors at the Dawn of this Decade

Roger Wood shares some thoughts about the key sectors that can expect a strong...

read more

A Day in the Life of a Midven Investment Analyst

Huw Sparkes has been part of the Midven team since joining as a graduate...

read more

More Companies in Medical / Biotechnology

Your browser is out-of-date!

Update your browser to view this website correctly.Update my browser now

×